Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells (MSV-allo) in Lupus Nephritis
NCT03673748Phase 2Recruiting
- Sponsor
- Red de Terapia Celular
- Start
- Dec 2022
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in lupus nephritis (LN), sponsored by Red de Terapia Celular. Started Dec 2022; status: recruiting.
02
Drugs
mesenchymal stem cells
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT03673748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03673748.